Earth Science Tech, Inc. Announces Interview on PotStockRadio, Contacto with Hilda Rabilero, & Floride TV

Hollywood, Florida, UNITED STATES

Doral, FL, Oct. 05, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, announces interview on PotStockRadio, Contacto with Hilda Rabilero show, and Floride TV show.


ETST plans on sharing it’s vision, story, structure, strategy, and growth with PotStockRadio. Broadcasting at 9PM EST, on Monday, October 9th, investors can visit to hear the interview in its entirety. PotStockRadio provides a voice for the legal marijuana and hemp financial sector. The network interviews CEO's and leaders of publicly traded companies related to American and Canadian Cannabis.

Contacto with Hilda Rabilero

ETST’s President, Director, & COO, Nickolas S. Tabraue was interviewed early September and and aired Sunday (9/24/17) on Contacto with Hilda Rabilero TV show. Mr. Tabraue presented ETST’s CBD products and shared it’s benefits along with a customer sharing her positive life changing experience. Contacto with Hilda Rabilero is aired on Mega TV channel 22 viewed heavily in the latin community on everyday topics. This opportunity opens the doors for ETST to spread awareness into the latin community as well as future show presence.

Floride TV

ETST’s CEO & CSO (Chief Science Officer), Dr. Michel Aube started his interview September 22nd  and will finalize the last segment soon to be aired during December and shared with Floride TV. Dr. Aube plans to share his vision, achievements, and his goals with ETST. Floride TV  is a premiere French channel focusing on various topics from music, sports, films, religion, and health. The interview will be translated in English to be shared with ETST’s share holders. 

Nickolas S. Tabraue concludes with, “I’m excited to see ETST receive so many amazing awareness opportunities to spread our vision and continue expanding our outreach to positively help many individuals. We have many exciting announcements and updates on our MSN-2 medical device, patents, KannaBidioiD subsidiary, distribution, education strategy, and expansion I look forward on sharing very soon.”

About Earth Science Tech, Inc. (ETST): Earth Science Tech has the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the world's best supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research performed alongside the University of Central Oklahoma and DV Biologics laboratory, prove we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil. 

To learn more please visit:

View ETST's accomplishments and reports on its High-Grade CBD Hemp Oil: (here)

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit:

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit:

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by it's unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit:

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products.

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.



Contact Data